The study evaluates the effects of Prazosin on agitation in adults with Alzheimer's disease.
Two thirds of the participants will participate in the medication portion, while one third
will participate in the placebo portion
Phase:
Phase 2
Details
Lead Sponsor:
Alzheimer's Disease Cooperative Study (ADCS)
Collaborators:
Alzheimer's Association National Institute on Aging (NIA) VA Puget Sound Health Care System